Idiopathic Pulmonary Fibrosis Latest Advances
Find the Latest Research About Idiopathic Pulmonary Fibrosis
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12075 publications
Fibrotic Interstitial Lung Diseases: CAR/CSTR Practice Guidelines for HRCT Diagnosis.
Journal: Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes
Published: October 28, 2026
Conserved Fibroblast Subsets Drive Shared Fibrotic Mechanisms in Osteoarthritis Synovium and Systemic Sclerosis Skin.
Journal: bioRxiv : the preprint server for biology
Published: October 25, 2026
Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: October 24, 2026
Bridging the GAP: Prognostic stratification by longitudinal FVC changes in IPF.
Journal: Journal of the Chinese Medical Association : JCMA
Published: October 24, 2026
Therapeutic advances in pulmonary fibrosis.
Journal: Therapeutic advances in respiratory disease
Published: October 24, 2026
Utility of Bronchoalveolar Lavage Fluid Cellular Composition in the Differential Diagnosis of Idiopathic Pulmonary Fibrosis: a preliminary study.
Journal: Malawi medical journal : the journal of Medical Association of Malawi
Published: October 22, 2026
Translation, Cultural Adaptation, and Validation of the Turkish Version of the St George's Respiratory Questionnaire for Idiopathic Pulmonary Fibrosis (SGRQ-I).
Journal: Thoracic research and practice
Published: October 21, 2026
Reply: Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-Year Real-Life Study.
Journal: Thoracic research and practice
Published: October 21, 2026
Effect of exportin-1 inhibitors on profibrotic responses in human lung fibroblasts.
Journal: Biochemical and biophysical research communications
Published: October 16, 2026
Connective tissue disease-associated interstitial lung disease: immune profiling and correlation of immune cells with pulmonary function in SSc-ILD.
Journal: Annals of medicine
Published: October 15, 2026
Nintedanib-induced Glomerular Microangiopathy after Long-term Nintedanib Administration Presenting with Nephrotic Syndrome.
Journal: Internal medicine (Tokyo, Japan)
Published: October 14, 2026
Inhalation therapies in interstitial lung diseases.
Journal: Expert opinion on drug delivery
Published: October 10, 2026
Last Updated: 11/08/2026